Hepatitis B Virus RNA Predicts Hepatocellular Carcinoma Despite Viral Suppression
Background
Despite achieving undetectable hepatitis B virus (HBV) DNA levels with nucleos(t)ide analogue (NA) therapy, patients with chronic hepatitis B (CHB) remain at risk of hepatocellular carcinoma (HCC). Novel covalently closed circular DNA activity biomarkers may improve risk stratification.
Aims
To comprehensively assess the association between serum HBV RNA and hepatitis B core‐related antigen (HBcrAg) levels, measured upon achieving undetectable HBV DNA levels, and subsequent HCC development in NA‐treated patients with CHB.
Methods
We retrospectively analysed 311 patients with CHB who achieved undetectable HBV DNA levels during NA therapy between 2000 and 2024. Serum HBV RNA (≥ 10 copies/mL) and HBcrAg (≥ 2.1 log U/mL) were measured in stored samples collected when HBV DNA first became undetectable. Cox regression analysis was performed to identify the factors associated with HCC development.
Results
During a median follow‐up of 11.0 years, 31 (10.0%) patients developed HCC. At viral suppression, 132 (42.4%) patients had HBV RNA ≥ 10 copies/mL. HCC incidence was significantly higher in patients with quantifiable HBV RNA than in those with unquantifiable HBV RNA (15‐year incidence, 17.8% vs. 8.8%,
p
= 0.026). Quantifiable HBV RNA independently predicted HCC (adjusted hazard ratio [aHR], 3.313; 95% confidence interval [CI]: 1.154–9.507;
p
= 0.026). HBcrAg showed no association (aHR, 0.821; 95% CI: 0.253–2.669;
p
= 0.743). Patients with quantifiable HBV RNA and albumin‐bilirubin score ≥ −2.60 had the highest risk (5‐year incidence: 15.8%).
Conclusions
HBV RNA levels at viral suppression predict HCC development in NA‐treated patients with CHB, outperforming HBcrAg. Incorporating HBV RNA assessment can improve risk‐stratified HCC surveillance strategies.
No keywords indexed for this article. Browse by subject →
Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi et al.
Philip J. Johnson, Sarah Berhane, Chiaki Kagebayashi et al.
Bruno Sangro, Josepmaria Argemi, Maxime Ronot et al.
Amit G. Singal, Josep M. Llovet, Mark Yarchoan et al.
Y Kanda
George Papatheodoridis, George Dalekos, Vana Sypsa et al.
Toshifumi Tada · 2025
- Published
- Dec 02, 2025
- Vol/Issue
- 63(8)
- Pages
- 1089-1098
- License
- View
You May Also Like
G. Vernon, A. Baranova · 2011
2,464 citations
H. M. HAMER, D. JONKERS · 2007
2,316 citations
C. Y. FRANCIS, J. Morris · 1997
1,407 citations
Yuan Tian, Long Rong · 2020
652 citations
S. Ben-Horin, Y. Chowers · 2011
545 citations